Screening Intracranial Aneurysms With Magnetic Resonance Angiography (MRA) in China
NCT ID: NCT00926172
Last Updated: 2009-12-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
4500 participants
OBSERVATIONAL
2007-06-30
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During the past decade, MRA, as a preferred accuracy modality for noninvasive intracranial vascular imaging at most centers, is playing an increasing role in the evaluation of patients suspected of having intracranial aneurysms. In recurrent study, we have tested that MRA at 3T has excellent sensitivity, accuracy, and correlation with DSA and is comparable to catheter cerebral angiography for the evaluation of patients with intracranial aneurysms (Stroke, in press). Therefore, we examined trends in intracranial aneurysm prevalence with the use of MRA at 3.0T to determine the true prevalence of cerebral intracranial aneurysms in the general middle-aged or elder population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 35-75 years
Exclusion Criteria
* Incompetent patient who cannot give consent for routine MR Angiography and his/her surrogate decision maker is not available
* Any patients with a contraindication to having a standard MRI examination, such as phase maker, orbital metallic foreign body, etc.
35 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Jiao Tong University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
The Sixth Affiliated People's Hospital, Shanghai Jiao Tong University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ming-Hua Li, MD, PhD
Role: STUDY_CHAIR
The Sixth Affiliated People's Hospital, Shanghai Jiao Tong University
Yong-Dong Li, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
The Sixth Affiliated People's Hospital, Shanghai Jiao Tong University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Sixth Affiliated People's Hospital, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yong-Dong Li, MD, Ph.D
Role: primary
Ming-Hua Li, MD, Ph.D
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
Li MH, Cheng YS, Li YD, Fang C, Chen SW, Wang W, Hu DJ, Xu HW. Large-cohort comparison between three-dimensional time-of-flight magnetic resonance and rotational digital subtraction angiographies in intracranial aneurysm detection. Stroke. 2009 Sep;40(9):3127-9. doi: 10.1161/STROKEAHA.109.553800. Epub 2009 Jun 25.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SAPH001
Identifier Type: -
Identifier Source: secondary_id
CASC1
Identifier Type: -
Identifier Source: org_study_id